Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 5

Zeitschriftenartikel

Leiter, Ulrike; Stadler, Rudolf; Mauch, Cornelia; Hohenberger, Werner; Brockmeyer, Norbert H.; Berking, Carola; Sunderkoetter, Cord; Kaatz, Martin; Schatton, Kerstin; Lehmann, Percy; Vogt, Thomas; Ulrich, Jens; Herbst, Rudolf; Gehring, Wolfgang; Simon, Jan-Christoph; Keim, Ulrike; Verver, Danielle; Martus, Peter und Garbe, Claus (2019): Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node. In: Journal of Clinical Oncology, Bd. 37, Nr. 32

Ugurel, Selma; Loquai, Carmen; Terheyden, Patrick; Schadendorf, Dirk; Richtig, Erika; Utikal, Jochen; Gutzmer, Ralf; Rass, Knuth; Sunderkötter, Cord; Stein, Annette; Fluck, Michäl; Kaatz, Martin; Trefzer, Uwe; Kähler, Katharina; Stadler, Rudolf; Berking, Carola; Höller, Christoph; Kerschke, Laura; Edler, Lutz; Kopp-Schneider, Annette und Becker, Jürgen C. (2017): Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial. In: Oncotarget, Bd. 8, Nr. 44: S. 76029-76043

Leiter, Ulrike; Stadler, Rudolf; Mauch, Cornelia; Hohenberger, Werner; Brockmeyer, Norbert; Berking, Carola; Sunderkötter, Cord; Kaatz, Martin; Schulte, Klaus-Werner; Lehmann, Percy; Vogt, Thomas; Ulrich, Jens; Herbst, Rudolf; Gehring, Wolfgang; Simon, Jan-Christoph; Keim, Ulrike; Martus, Peter und Garbe, Claus (2016): Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. In: Lancet Oncology, Bd. 17, Nr. 6: S. 757-767

Zimmer, Lisa; Eigentler, Thomas K.; Kiecker, Felix; Simon, Jan; Utikal, Jochen; Mohr, Peter; Berking, Carola; Kaempgen, Eckhart; Dippel, Edgar; Stadler, Rudolf; Hauschild, Axel; Fluck, Michael; Terheyden, Patrick; Rompel, Rainer; Loquai, Carmen; Assi, Zeinab; Garbe, Claus und Schadendorf, Dirk (2015): Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma. In: Journal of Translational Medicine 13:351 [PDF, 1MB]

Tony, Hans-Peter; Burmester, Gerd; Schulze-Koops, Hendrik; Grunke, Mathias; Henes, Joerg; Kötter, Ina; Haas, Judith; Unger, Leonore; Lovric, Svjetlana; Haubitz, Marion; Fischer-Betz, Rebecca; Chehab, Gamal; Rubbert-Roth, Andrea; Specker, Christof; Weinerth, Jutta; Holle, Julia; Müller-Ladner, Ulf; König, Ramona; Fiehn, Christoph; Burgwinkel, Philip; Budde, Klemens; Sörensen, Helmut; Meurer, Michael; Aringer, Martin; Kieseier, Bernd; Erfurt-Berge, Cornelia; Sticherling, Michael; Veelken, Roland; Ziemann, Ulf; Strutz, Frank; Meier, Florian M. P.; Hunzelmann, Nico; Schmidt, Enno; Bergner, Raoul; Schwarting, Andreas; Eming, Rüdiger; Hertl, Michael; Stadler, Rudolf; Schwarz-Eywill, Michael; Wassenberg, Siegfried; Fleck, Martin; Metzler, Claudia; Zettl, Uwe; Westphal, Jens; Heitmann, Stefan; Herzog, Anna L.; Wiendl, Heinz; Jakob, Waltraud; Schmidt, Elvira; Freivogel, Klaus und Dörner, Thomas (2011): Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID). In: Arthritis Research & Therapy 13:R75 [PDF, 694kB]

Diese Liste wurde am Sat Mar 16 22:07:31 2024 CET erstellt.